| 2026-08-05 | Press release | Second Quarter 2026 |
| 2026-08-05 | Earnings deck | Q2 2026 Insulet Corporation Earnings Call Presentation |
| 2026-08-05 | Press release | Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026 |
| 2026-07-14 | Press release | Download , Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a N |
| 2026-07-14 | Press release | Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep St |
| 2026-07-06 | Presentation | Download PDF file, (opens in new window) |
| 2026-07-06 | Press release | Download , Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discover™ in Spain, Expanding Access |
| 2026-07-06 | Press release | Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discover™ in Spain, Expanding Access to Tubeless |
| 2026-07-01 | Press release | Download , Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026, July 1, 2026, (opens in new wind |
| 2026-06-25 | Press release | Download , Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors, June 25, 2026, (opens in new |
| 2026-06-06 | Press release | Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcom |
| 2026-06-04 | Press release | Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Str |
| 2026-06-03 | Presentation | Presentation Open Event Link, PDF file, June 3, 2026, (opens in new window) |
| 2026-06-03 | Press release | Insulet to Participate in William Blair 46th Annual Growth Stock Conference |
| 2026-06-03 | Press release | Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre |
| 2026-05-27 | Press release | Download , Insulet to Participate in William Blair 46th Annual Growth Stock Conference, May 27, 2026, (opens in new wind |
| 2026-05-26 | Press release | Download , Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected Inte |
| 2026-05-22 | Presentation | Download PDF (opens in new window) |
| 2026-05-06 | Earnings deck | Presentation
PDF
839 KB |
| 2026-05-06 | Press release | Download , Insulet Reports First Quarter 2026 Results, May 6, 2026, (opens in new window) |
| 2026-05-05 | Press release | Download , Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities, May 5, 2026, ( |
| 2026-05-04 | Press release | Download , Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Typ |
| 2026-04-30 | ESG report | Read Our 2025 Sustainability Report |
| 2026-04-28 | Press release | Download , Insulet to Participate in BofA Securities 2026 Health Care Conference, April 28, 2026, (opens in new window) |
| 2026-03-12 | Press release | Download , Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S., March 12, 2026 |
| 2026-03-11 | Press release | Download , Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults w |
| 2026-02-18 | Press release | Q4 |
| 2026-02-18 | Earnings deck | Q4 2025 Insulet Corporation Earnings Call Presentation |
| 2026-01-13 | Presentation | Insulet Presents at J.P. Morgan Healthcare Conference 2026 Open Event Link, PDF file, January 13, 2026, (opens in new wi |
| 2025-11-06 | Earnings deck | Q3 2025 Insulet Corporation Earnings Call Presentation |
| 2025-11-06 | Press release | Q3 |
| 2025-08-07 | Press release | Q2 |
| 2025-05-08 | Press release | Q1 |
| 2025-05-08 | Press release | Press Release(opens in new window) |
| 2025-02-20 | Press release | Q4 |
| 2024-11-07 | Press release | Q3 |
| 2024-08-08 | Press release | Q2 |
| 2024-05-09 | Press release | Q1 |
| 2024-02-22 | Press release | Press Release(opens in new window) |
| 2023-11-02 | Press release | Q3 |